TLDR Immunological treatment improved both neuropathy and alopecia.
A 42-year-old male experienced whole body alopecia and limb weakness, initially unresponsive to prednisolone. Diagnosed with multifocal acquired demyelinating sensory and motor neuropathy in 2011, he was treated with intravenous immunoglobulin (IVIg), which improved muscle strength. After three years, he experienced remitting limb weakness and received IVIg again, resulting in improvement of both alopecia and limb weakness. This case suggested an immunological pathomechanism linking the neuropathy and alopecia, as both conditions improved with immunomodulatory treatment.
122 citations
,
November 1984 in “Journal of the American Academy of Dermatology” No single treatment is consistently effective for alopecia areata, and more research is needed.
2 citations
,
May 2021 in “Neuropathology & applied neurobiology/Neuropathology and applied neurobiology” Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.
1 citations
,
April 2017 in “Journal of Dermatology and Dermatologic Surgery” IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.
January 2025 in “Frontiers in Immunology” IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.
105 citations
,
February 2017 in “British Journal of Dermatology” Survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis need ongoing care for various long-term health problems.
3 citations
,
March 2021 in “Clinical, Cosmetic and Investigational Dermatology” Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.
